PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
---|---|---|---|---|---|---|---|
28880460 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | heart failure | NA | nitrogen | NA | unclassified | |
four out of ten heart failure patients developed donor-specific de novo human leukocyte antigen (hla) class i antibodies, and two out of ten patients had donor-specific hla antibodies already at baseline. | |||||||
30672659 | HLA-A (HLA-A) | heart failure | NA | NA | NA | unclassified | |
determination of hla-a, -b, -c, -drb1 and -dqb1 allele and haplotype frequencies in heart failure patients. | |||||||
30672659 | HLA-DRB1 (HLA-DRB1) | heart failure | NA | NA | NA | unclassified | |
determination of hla-a, -b, -c, -drb1 and -dqb1 allele and haplotype frequencies in heart failure patients. | |||||||
30672659 | HLA-DQB1 (HLA-DQB1) | heart failure | NA | NA | NA | unclassified | |
determination of hla-a, -b, -c, -drb1 and -dqb1 allele and haplotype frequencies in heart failure patients. | |||||||
30672659 | HLA (HLA) | heart failure | NA | NA | NA | unclassified | |
the present study investigates the hla allele and haplotype frequencies in a cohort of heart failure (hf) patients. | |||||||
31806379 | HLA-G (HLA-G) | heart failure | NA | NA | NA | unclassified | |
plasma soluble hla-g levels in a cohort of heart failure patients exposed to chemicals. | |||||||
31806379 | HLA-G (HLA-G) | heart failure | NA | NA | NA | only_studied | |
we evaluated soluble (s)hla-g plasmatic levels in patients with stable chronic heart failure at baseline visit and after 6 and 12 months. | |||||||
32602534 | HLA-DPB1 (HLA-DPB1) | heart failure | NA | NA | NA | only_studied | |
three key genes, stk39, hla-dpb1 and rab5c, which may be key genes for diabetic heart failure, were identified. | |||||||
34504489 | HLA (HLA) | heart failure | NA | NA | NA | unclassified | |
in addition to pregnancy, prior transplant, and transfusions, patients with end-stage heart failure are burdened with unique factors placing them at risk for hla sensitization. | |||||||
7963113 | HLA-DR (HLA-DR) | aortic stenosis | NA | calcium | NA | unclassified | |
expression of hla-dr antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis. |
Copyright 2024